Simplex Trading’s Centessa Pharmaceuticals CNTA Stock Holding History

Simplex Trading’s Portfolio CNTA Stock Details CNTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-2,622	Closed	-$63K	–	8739
2025 Q3	$63K	Buy	+2,622	New	+$46.6K	﹤0.01%	6220
2024 Q4	–	Sell	-108	Closed	-$1K	–	8637
2024 Q3	$1K	Buy	+108	New	+$1.32K	﹤0.01%	8158
2023 Q3	–	Sell	-38	Closed	-$260	–	8788
2023 Q2	$0	Buy	+38	New	+$180	﹤0.01%	9086
2023 Q1	–	Sell	-60	Closed	–	–	9137
2022 Q4	$0	Hold	60	–	–	﹤0.01%	9333
2022 Q3	$0	Buy	+60	New	+$274	﹤0.01%	10006

Simplex Trading's CNTA Position: Q4 2025 in Review

Simplex Trading sold out of Centessa Pharmaceuticals (CNTA) in Q4 2025, closing a stake of 2,622 shares — an estimated $63K sold.

Simplex Trading first reported a position in CNTA in Q3 2022 and held it in 5 quarters. The position peaked at $63K in Q3 2025. 146 funds tracked by Wall St. Rank hold CNTA as of Q4 2025.

Simplex Trading reported no remaining Centessa Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
Simplex Trading sold 2,622 Centessa Pharmaceuticals shares in Q4 2025, an estimated $63K.
Simplex Trading first reported a position in Centessa Pharmaceuticals in Q3 2022 and held it in 5 quarters.
Simplex Trading's Centessa Pharmaceuticals position peaked at $63K in Q3 2025.
146 funds tracked by Wall St. Rank held Centessa Pharmaceuticals as of Q4 2025.

Based on Simplex Trading's 13F filing for Q4 2025, filed 11 Feb 2026.